Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy
Author:
Affiliation:
1. Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine
2. Division of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/jat/24/2/24_32615/_pdf
Reference36 articles.
1. 1) Cholesterol Treatment Trialists' (CTT) Collaboration. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, and Collins R: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 2010; 376: 1670-1681
2. 2) LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, and Wenger NK; Treating to New Targets (TNT) Investigators: Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med, 2005; 352: 1425-1435
3. 3) Chapman MJ, Redfern JS, McGovern ME, and Giral P: Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk. Pharmacol Ther, 2010; 126: 314-345
4. 4) Miettinen TA, Gylling H, Lindbohm N, Miettinen TE, Rajaratnam RA, and Relas H; Finnish Treat-to-Target Study Investigators: Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. J Lab Clin Med, 2003; 141: 131-137
5. 5) Hoshiga M, Arishiro K, Nakakoji T, Miyazaki N, Negoro N, Okabe T, Kohbayashi E, Ishihara T, and Hanafusa T: Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease. J Atheroscler Thromb, 2010; 17: 705-711
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia;Disease Markers;2022-04-21
2. Evaluation of Event Risks of Cerebro- and Cardiovascular Diseases by Focusing on the Profile of Atherogenic Lipoproteins Developing Atherosclerotic Plaque, not the Value of Lipids;Health Evaluation and Promotion;2020-11-10
3. Noncholesterol Sterols and Sitosterolemia in Clinical Practice;Journal of Atherosclerosis and Thrombosis;2020-05-01
4. Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial;PLOS ONE;2020-01-28
5. Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 gene;Lipids in Health and Disease;2020-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3